Skip to main content
. 2012 Nov 1;4(6):710–723. doi: 10.4161/mabs.22160

graphic file with name mabs-4-710-g5.jpg

Figure 5. Lead c-Met antibodies show differential antitumor activity against S114 tumors. S114 tumors were injected subcutaneously into athymic mice and after tumors were established for five days, each mouse received a single 200 μg bolus dose (~10 mg/kg) of a lead c-Met antibody (arrow). Caliper measurements were made every 2–3 d. Values are means ± SEM.